Crescita Therapeutics (TSX:CTX) Inventory Turnover: 0.67 (As of Mar. 2026)

What is Crescita Therapeutics Inventory Turnover?

Crescita Therapeutics TSX:CTX 20 Inventory Turnover is 0.67 as of Mar. 2026. GuruFocus rates TSX:CTX with a GF Score™ of 20/100 and a GF Value™ of C$0.68 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Crescita Therapeutics's Cost of Goods Sold for the three months ended in Mar. 2026 was C$2.99 Mil. Crescita Therapeutics's Average Total Inventories for the quarter that ended in Mar. 2026 was C$4.45 Mil. Crescita Therapeutics's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.67.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Crescita Therapeutics's Days Inventory for the three months ended in Mar. 2026 was 135.61.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Crescita Therapeutics's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.79.

Crescita Therapeutics (TSX:CTX) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Crescita Therapeutics's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2026 )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
	=	4.448	/	2.993	*	365 / 4
	=	135.61

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Crescita Therapeutics's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	4.448	/	5.637
	=	0.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Crescita Therapeutics Inventory Turnover Related Terms

Crescita Therapeutics Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Crescita Therapeutics's Inventory Turnover can be seen below:

Crescita Therapeutics Inventory Turnover Chart

Crescita Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

1.72

2.06

1.22

2.08

2.28

Crescita Therapeutics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Inventory Turnover	Get a 7-Day Free Trial															0.43	0.48	0.49	0.65	0.67

20GF Score

Crescita Therapeutics Inc TSX:CTX

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Crescita Therapeutics Inventory Turnover Calculation

Crescita Therapeutics's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	10.009	/ (	(4.051	+	4.722)	/	2 )
=	10.009	/	4.3865
=	2.28

Crescita Therapeutics's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

	Inventory Turnover (Q: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2026 )	/ (	(Total Inventories (Q: Dec. 2025 )	+	Total Inventories (Q: Mar. 2026 ))	/	count )
=	2.993	/ (	(4.722	+	4.174)	/	2 )
=	2.993	/	4.448
=	0.67

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.67 mean?

Crescita Therapeutics (TSX:CTX) has a Inventory Turnover of 0.67 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Crescita Therapeutics and its competitors.

Is Crescita Therapeutics' Inventory Turnover too high?

Crescita Therapeutics' current Inventory Turnover is 0.67. Overall, Crescita Therapeutics has a GF Score™ of 20/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Crescita Therapeutics' Inventory Turnover compare to ZTS?

Crescita Therapeutics' Inventory Turnover of 0.67 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Drug Manufacturers company?

A good Inventory Turnover depends on the Drug Manufacturers industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Crescita Therapeutics and its competitors. Crescita Therapeutics's current Inventory Turnover is 0.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Crescita Therapeutics stock overvalued right now?

Based on GuruFocus' analysis, Crescita Therapeutics (TSX:CTX) is currently considered Modestly Overvalued. The stock's GF Value™ is C$0.68, compared to a current price of C$0.79 — trading 16.2% above its estimated fair value. The current Inventory Turnover is 0.67. Crescita Therapeutics' overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Crescita Therapeutics (TSX:CTX), the current Inventory Turnover is 0.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Crescita Therapeutics (TSX:CTX) Overvalued in 2026?

Based on GuruFocus' analysis, Crescita Therapeutics stock appears to be overvalued. The current stock price of C$0.79 is trading 16.2% above its estimated GF Value™ of C$0.68. GuruFocus considers Crescita Therapeutics to be Modestly Overvalued.

Key valuation signals for TSX:CTX:

Inventory Turnover: 0.67
GF Value™: C$0.68 vs. price of C$0.79 (16.2% above fair value)
GF Score™: 20/100 with 5 warning signs

No single metric tells the full story. See the TSX:CTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Crescita Therapeutics Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies XCNQ:RWB XCNQ:RVV TSXV:VM XCNQ:PWR TSX:AVCN TSXV:PCLO TSXV:MPH TSX:AVNT XCNQ:OILS XCNQ:GWAY XTER:MRK TSE:4502 XSWX:GALD SHSE:600276 NSE:SUNPHARMA XTAE:TEVA LSE:HLN XSWX:SDZ ZTS HKSE:03692

Address 2805, Place Louis-R-Renaud, Laval, QC, CAN, H7V 0A3

Website https://www.crescitatherapeutics.com

Crescita Therapeutics Inc is a commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The company has three reportable segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The firm generates its revenue from Commercial Skincare Product Sales in Canada followed by USA and Rest of the world.

20GF Score

Get the complete analysis for TSX:CTX

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.79

Price

C$0.68

GF Value

View TSX:CTX Analysis

See Inventory Turnover data for all stocks →